- Home
- INMD vs NXP Comparison
INMD vs NXP Comparison
Compare INMD & NXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | INMD | NXP |
|---|---|---|
| Founded | 2008 | N/A |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 842.0M | 744.2M |
| IPO Year | 2018 | 1995 |
Fundamental Metrics
Financial Performance| Metric | INMD | NXP |
|---|---|---|
| Price | $14.81 | $14.40 |
| Analyst Decision | Hold | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $17.33 | N/A |
| AVG Volume (30 Days) | ★ 739.4K | 137.7K |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $1.74 | N/A |
| Revenue Next Year | $3.26 | N/A |
| P/E Ratio | $10.11 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.72 | $13.73 |
| 52 Week High | $16.74 | $14.65 |
Technical Indicators
Market Signals| Indicator | INMD | NXP |
|---|---|---|
| Relative Strength Index (RSI) | 66.80 | 58.76 |
| Support Level | $14.58 | $14.35 |
| Resistance Level | $15.23 | $14.49 |
| Average True Range (ATR) | 0.27 | 0.10 |
| MACD | 0.14 | 0.01 |
| Stochastic Oscillator | 80.30 | 71.70 |
Price Performance
Historical ComparisonAbout INMD InMode Ltd.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.
About NXP Nuveen Select Tax Free Income Portfolio
Nuveen Select Tax Free Income Portfolio is a closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax, consistent with preservation of capital. The fund invests a majority of its assets in municipal securities and other related investments, the income from which is exempt from regular federal income tax and federal alternative minimum tax.